All (2)News (2)Transcripts (0)Press Releases (0)

News66 days ago

SAB Bio Shares Falter Amid Positive but Non-Conclusive Presentation

SAB Biotherapeutics shares are trading lower despite presenting positive data at EASD, as investors await more definitive clinical trial outcomes.

News126 days ago

SAB BIO Stock Jumps on Successful $175 Million Private Placement

SAB BIO shares are trading higher after announcing an oversubscribed $175 million private placement, which will fund the Phase 2b study of SAB-142 for T1D.